Wolff-parkinson-white syndrome and atrioventricular nodal re-entry tachycardia in a swedish population: Consequences on health-related quality of life

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 10, 2009, Pages 1299-1306

  Walfridsson, Ulla ^a,b   StrÖmberg, Anna ^a,b   Janzon, Magnus ^b   Walfridsson, HÅkan ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrioventricular nodal re entry tachycardia; EQ 5D; Health related quality of life; Matched reference groups; Paroxysmal supraventricular tachycardia; Radiofrequency ablation; SF 36; Wolff Parkinson White

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REENTRY TACHYCARDIA; SEX DIFFERENCE; SHORT FORM 36; SOCIAL INTERACTION; SWEDEN; WOLFF PARKINSON WHITE SYNDROME;

ADULT; AGE DISTRIBUTION; CATHETER ABLATION; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; SEX DISTRIBUTION; SWEDEN; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 70349542920     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02476.x     Document Type: Article

References (30)

1. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996 94 : 1585 1591.
2. Brembilla-Perrot B, Beurrier D, Houriez P, Claudon O, Wertheimer J. Incidence and mechanism of presyncope and/or syncope associated with paroxysmal junctional tachycardia. Am J Cardiol 2001 88 : 134 138.
3. Walfridsson U, Walfridsson H. The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation. Pacing Clin Electrophysiol 2005 28 : 191 195.
4. Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol 1997 79 : 145 149.
5. Socialstyrelsen. Stockholm, The Swedish National Board of Health and Welfare's Guidelines for Cardiac Care 2004, 2004.
6. Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 1998 82 : 589 593.
7. WHO. The constitution of the World Health Organization. WHO Chron 1947 1:29.
8. Kuyken W, on behalf of the WHOQOL group. The World Health Organization Quality of Life Assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med 1995 41 : 1403 1409.
9. Sullivan M, Karlsson J. Hälsoenkät. Svensk manual och tolkningsguide. (Swedish manual and interpretation guide). Gothenburg, Health Care Research Unit, Medical Faculty, Gothenburg University and Sahlgrenska Hospital, Gothenburg, 1994.
10. Keller SD, Ware JE, Jr., Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, et al. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998 51 : 1179 1188.
11. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: Results from normative population. J Clin Epidemiol 1998 51 : 1105 1113. (Pubitemid 28527166)
12. Sullivan M, Karlssson J, Ware JE Jr. The Swedish SF-36 Health Survey - I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995 41 : 1349 1358.
13. Ware JE Jr., Sherbourne C. The MOS 36-item Short-Form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992 30 : 473 483.
14. Ware J Jr., Snow K, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, The Health Institute, New England Medical Center, 1993.
15. ® Health Survey: Manual & Interpretation Guide. Lincoln, RI, Quality Metric Inc., 2005.
16. Ware JE, Jr., Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care 1995 33 : AS264 AS279.
17. Ware JE Jr., Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales-A User's Manual. Boston, The Health Institute. 1994.
18. Brooks R. EuroQol: The current state of play. Health Policy 1996 37 : 53 72.
19. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993 2 : 169 180.
20. Brooks RG, Jendteg S, Lindgren B, Persson U, Bjork S. EuroQol: Health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 1991 18 : 37 48.
21. Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001 33 : 337 343.
22. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997 35 : 1095 1108.
23. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 2003 4 : 222 231.
24. Hamer ME, Blumenthal JA, McCarthy EA, Phillips BG, Pritchett EL. Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. Am J Cardiol 1994 74 : 826 829.
25. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation 1993 88 : 282 295.
26. Al-Khatib SM, Pritchett EL. Clinical features of Wolff-Parkinson-White syndrome. Am Heart J 1999 138 : 403 413.
27. Hlatky MA, Vaughn WK. Quality of life in patients with supraventricular arrhythmia. Circulation 1996 94 : 1491 1493.
28. Liuba I, Jonsson A, Safstrom K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006 97 : 384 388.
29. Insulander P, Englund A, Jensen SM, Johansson B, Kongstad O, Scwieler J, Walfridsson H. Ablation of AVNRT - Results in 2.830 patients during 10 years, 1997-2006. Europace 2008 10 (Suppl 1 149.
30. Dhala A, Bremner S, Blanck Z, Sra J, Deshpande S, Jazayeri MR, Akhtar M. Impairment of driving abilities in patients with supraventricular tachycardias. Am J Cardiol 1995 75 : 516 518.